Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Prime Medicine
company
Funding Round
Series B
Money Raised
$ 200M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| ARCH Venture Partners | - | - | - | Detail |
| Arrive | - | - | - | Detail |
| Casdin Capital | - | - | - | Detail |
| Cormorant Asset Management | - | - | - | Detail |
| F-Prime Capital | - | - | - | Detail |
| GV | - | - | - | Detail |
| Moore Strategic Ventures | - | - | - | Detail |
| Newpath Management | - | - | - | Detail |
| PSP Investments | - | - | - | Detail |
| Redmile Group | - | - | - | Detail |
| Samsara BioCapital | - | - | - | Detail |
| T. Rowe Price | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Oct 22, 2019 | Series A | $ 115M | ARCH Venture Partners,Arrive,etc. | Detail |
